Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuroBo Pharmaceuticals, Inc.

2.36
0.0000
Volume:- -
Turnover:31.15K
Market Cap:20.33M
PE:-0.55
High:2.36
Open:2.36
Low:2.36
Close:2.36
Loading ...
May 26, 2020

Major Issues Report

8-K - Current report
May 20, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 15, 2020

Major Issues Report

8-K - Current report
Apr 01, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 30, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2020

Major Issues Report

8-K - Current report
Feb 20, 2020

Major Issues Report

[Amend] Current report, item 9.01
Feb 13, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Feb 13, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 04, 2020

Major Issues Report

Current report, item 1.01
Jan 22, 2020

Major Issues Report

[Amend] Current report, item 9.01
Jan 16, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jan 13, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Jan 10, 2020

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Jan 10, 2020

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Jan 10, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jan 09, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 07, 2020

Major Issues Report

[Amend] Current report, items 4.01, 5.02, and 9.01
Dec 31, 2019

Major Issues Report

Current report, items 1.01, 1.02, 2.01, 2.04, 3.03, 4.01, 5.01, 5.02, and 9.01
Dec 30, 2019

Business Combinations

Prospectuses and communications, business combinations